Barriers to clinical trial participation in patients at UCLH

  • Research type

    Research Study

  • Full title

    Research into barriers to clinical trial participation (including the recruitment process) in patients at UCLH

  • IRAS ID

    318718

  • Contact name

    Rosamund Yu

  • Contact email

    rosamund.yu@ucl.ac.uk

  • Sponsor organisation

    UCLH/UCL

  • Clinicaltrials.gov Identifier

    Z6364106/2022/08/15, UCL Data Protection Office

  • Duration of Study in the UK

    1 years, 11 months, 30 days

  • Research summary

    Clinical research is essential for investigating the safety and efficacy of innovative treatments; however, there is significant disparity in patients being able to participate in this research across the UK. This challenge is exemplified in ethnic minorities and nuanced by disease area. For example, the Alzheimer’s Society predicts that there will be 50,000 UK ethnic minority patients with dementia by 2026, but despite the rising numbers, these communities still face multiple barriers in accessing trials and are under-represented as participants in Alzheimer's research. Not only are patients potentially missing out on valid treatment options, the under-enrolment of patients from minority ethnic groups can reduce the generalisability of any research findings and therefore more needs to be done to improve our understanding of why there is under-enrolment and how it can be addressed (Alzheimer's Society, 2022).

    Barriers to participation among minority ethnic patient populations in research can include cultural barriers, as well as general distrust in research and the healthcare system. There is also the potential for healthcare professionals to have a subconscious bias when selecting patients to be approached about clinical trials. The National Institute for Health and Care Research (NIHR) highlights the importance of understanding these obstacles and tailoring solutions (NIHR, 2020). UCLH and collaborator Roche is looking to address these barriers to clinical trial participation and advancing inclusive research globally.

    The study will take a qualitative approach, conducting semi-structure interviews with staff and patients across four disease areas at UCLH clinics.

    The output of this research will be the identification of the barriers during the recruitment process to recruiting ethnic minority participants and recommendations as to measures to address these barriers. This will pave the way for a further study to trial the recommended measures.

  • REC name

    Wales REC 3

  • REC reference

    23/WA/0116

  • Date of REC Opinion

    28 Mar 2023

  • REC opinion

    Favourable Opinion